企業プロフィール
Helius Medical Technologies 株価・ニュース・カタリスト
- ティッカー:
- HSDT
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
2.10 USD (+12.90%)
終値
最終更新: 2026年8月21日
93.4M USD
時価総額
株価変動の要因
As of Aug 21, 2026, HSDT closed up 12.9% at $2.10. No new same-company headline was identified in the current news window.
企業概要
事業概要
Helius Medical Technologies is a medical technology company focused on neuromodulation and non-invasive approaches to neurological symptoms. Its business is rooted in device-based neuroscience rather than pharmaceuticals.
所在地とセクター分類
Helius is headquartered in the United States and listed on NASDAQ. It sits in neurotechnology and medical devices.
ビジネスモデルの特徴
The company depends on product adoption, clinical acceptance, and the ability to expand use of its neuromodulation platform. Investors usually watch commercialization progress and regulatory or reimbursement developments.
バイオ業界での位置付け
Helius occupies a neuromodulation niche within healthcare technology. It is not biotech, but it sits close to the neuroscience device layer.
今後のカタリスト
- Helius is a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. There is no active standalone growth story left.
最近のニュース
- 01
- 02
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。